ENDRA Life Sciences to Participate in the H.C. Wainwright 5th Annual NASH Investor Conference
05 Outubro 2021 - 09:00AM
Business Wire
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of
Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that
management will participate in the H.C. Wainwright 5th Annual NASH
Investor Conference on Tuesday, October 12, 2021. Management will
deliver a company presentation at 2:00 p.m. Eastern Time and will
be available for virtual one-on-one meetings with investors
throughout the day.
About ENDRA Life Sciences Inc.
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced
UltraSound (TAEUS®), a ground-breaking technology being developed
to visualize tissue like MRI, but at 1/50th the cost and at the
point of patient care. TAEUS® is designed to work in concert with
400,000 cart-based ultrasound systems in use globally today. TAEUS®
is initially focused on the measurement of fat in the liver as a
means to assess and monitor Non-Alcoholic Fatty Liver Disease
(NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver
conditions that affect over one billion people globally, and for
which there are no practical diagnostic tools. Beyond the liver,
ENDRA is exploring several other clinical applications of TAEUS®,
including visualization of tissue temperature during energy-based
surgical procedures. For more information, please visit
www.endrainc.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211005005009/en/
Company Contact: Irina Pestrikova Senior Director,
Finance investors@endrainc.com www.endrainc.com
Investor Relations Contact: Yvonne Briggs LHA Investor
Relations (310) 691-7100 YBriggs@lhai.com
ENDRA Life Sciences (NASDAQ:NDRA)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
ENDRA Life Sciences (NASDAQ:NDRA)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024